International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...

Full description

Bibliographic Details
Main Authors: Fanny Ofek, Dana Barchel, Nofar Perets, Tomer Ziv-Baran, Ahmad Mahajna, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, Maya Berlin, Matitiahu Berkovitch
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Pharmacology
Subjects:
rivaroxaban
apixaban
INR
anti-FXa activity
direct oral anti- FXa anticoagulants
anti-FXa chromogenic assay
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01177/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01177/full

Similar Items